All News

01:17am Roche, Zealand Pharma Obesity Drug Hits Goal in Midstage Trial DJ
12:31am Roche's obesity drug shows up to 10.7% weight loss in mid-stage trial RE
09:12pm Eli Lilly and Company Launches Employer Connect Platform with Tailored Obesity Coverage Options CI
08:16pm Global markets live: Broadcom, Berkshire Hathaway, Morgan Stanley, Intel, Eli Lilly… Zonebourse
05:53pm Eli Lilly launches employer connect platform, introducing new obesity coverage options RE
05:21pm Eli Lilly Launches Employer Platform to Expand Access to Obesity Drugs MT
04:39pm Irish domestic economy grew by 4.9% in 2025, GDP jumped 12.3% RE
04:36pm Lilly launches employer-connect platform to broaden weight-loss drug access RE
04:31pm Lilly Employer Connect platform launches with over fifteen independent program administrators offering tailored obesity coverage options to expand access to patients PR
05:01am GLP-1 drugs protect against new or worsening addictions, large study shows RE
05/03 Johnson & Johnson launches website for direct-to-consumer sales RE
05/03 Eli Lilly and Company completed the acquisition of Ventyx Biosciences, Inc. from New Science Ventures, LLC, Affinity Asset Advisors, LLC, The Vanguard Group, Inc., and others. CI
04/03 Entera Bio Submits Streamlined Phase 3 Protocol to Initiate Registrational Program for EB613 in Postmenopausal Women with Osteoporosis CI
04/03 When Talk of Talks Moves Markets Zonebourse
04/03 Drugmaker Aspen targets Mounjaro approval in sub-Saharan Africa this year RE
04/03 Strive Pharmacy says it will not resume compounded oral semaglutide sales RE
04/03 US FDA warns 30 telehealth firms over misleading ads for compounded weight-loss drugs RE
03/03 Aspen Pharmacare expects Canada entry with Ozempic generic by third quarter RE
03/03 Hims' pharmacy partner will reintroduce GLP-1 pill pulled from market, Endpoints News reports RE
03/03 From Calm to Caution Zonebourse
03/03 Roche to Enter Weight-loss Drugs Market in 2029, CEO Says MT
03/03 Short war? Long war? Zonebourse
03/03 Eli Lilly and Company Presents at TD Cowen 46th Annual Health Care Conference, Mar-02-2026 03:10 PM
03/03 Eli Lilly on track to launch oral obesity drug in second quarter, pending US approval (March 2) RE
03/03 US asks smaller drugmakers to discuss lowering prices for Medicaid RE
No results for this search
  1. Stock Market
  2. Equities
  3. LLY Stock
  4. News Eli Lilly and Company